Moreover, inhibition of FGFR‐2 resulted in smaller tumours in nude mice, suggesting that FGFR‐2 could be a potential target for pancreatic cancer.91 Similarly, inhibition of FGFR signalling using shRNA led to cell kill in pancreatic cancer cells. Here, FGFR2 is linked to pancreatic neoplasm.